Navigation Links
ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
Date:3/3/2009

Interest expense (785) (525) Interest income 1 264 888 Exchange gain (loss) (700) 16 Loss before tax (8 015) (11 015) Tax benefit 675 2 089 Net income (loss) (7 340) (8 925) Weighted average number of shares outstanding 25 567 786 26 780 441 Net loss per share (0.29) (0.33) EXONHIT THERAPEUTICS S.A. CONSOLIDATED BALANCE SHEET (in thousands of euros) ASSETS Dec. 31, 2007 Dec. 31, 2008 Intangible assets, net 81 556 Property and equipment, net 1 929 2 220 Other long term assets 1 664 269 Total long-term assets 3 674 3 046 Accounts and grants receivable 1 151 1 057 Other short term assets 1 422 4 695 Cash and cash equivalents 31 342 21 049 Total short-term assets 33 914 26 801 TOTAL ASSETS 37 589 29 847 LIABILITIES AND SHAREHOLDERS' EQUITY Share capital 427 430 Additional paid-in capital 70 392 70 650 Accumulated deficit (53 426) (62 351) Other 672 1 011 Shareholders' equity 18 066 9 739
'/>"/>
SOURCE ExonHit Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)
2. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
3. Loic Maurel Joins Exonhit Therapeutics to Become CEO
4. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
5. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
6. ExonHit Appoints a New Management Board
7. ExonHit Therapeutics - 2007 Financial Results
8. ExonHit Builds A New Organisation
9. ExonHit and bioMerieux Amend Their Strategic Partnership
10. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
11. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 27, 2015 Research and Markets( ... PharmaBiotech,s new report "Neuroprotection - Drugs, Markets ... This report describes the role of neuroprotection in ... the nervous system as well as in chronic ... the underlying mechanisms of damage to neural tissues ...
(Date:5/28/2015)... 28, 2015 Celsion Corporation (the "Company") (NASDAQ: ... commitments from two institutional healthcare investors to purchase an ... stock in an at-the-market registered direct offering and a ... The Company entered into a definitive purchase ... agreed to sell an aggregate of 3,000,000 shares of ...
(Date:5/28/2015)... DryLet, LLC a biotechnology company providing ... animal waste reduction, bioremediation, wastewater treatment, aquaculture and ... plants and restaurant kitchen settings, announced today it ... 3-5 in Des Moines, Iowa. , ManureMagicâ„¢ was ... Journal article because of its industry-leading qualities and ...
(Date:5/28/2015)... 2015  PDS Biotechnology Corp. announces preliminary data ... HPV-16, has generated strong T-cell responses in pre-cervical ... is treated by surgical removal of lesions however, ... alternative. Results show that it primes and activates ... and kill precancerous and cancerous cells that display ...
Breaking Biology Technology:Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3DryLet to Showcase Patented ManureMagicâ„¢ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2
... Gizmox, the developer of Visual WebGui Web ... the Business Mobility Market. Visual WebGui,s Instant CloudMove migration, ... Web or Cloud, has now been extended to make ... mapping and configuration tool.  IdeoMobile, in partnership with Gizmox, ...
... Patent 7,824,612 ("Body Fluid Analyzer and System including Same and ... of their patented Technology to create a new class of ... analyzers. These tablets wirelessly inform a body fluid ... the drug company so that the analyzer can provide alerts ...
... AVAX Technologies, Inc. (Pink Sheets: AVXT ... filed a Form 10 with the Securities and Exchange ... AVAX will once again become a publicly reporting company. ... stock trade on the Over-the-Counter Bulletin Board.  The Company,s ...
Cached Biology Technology:Gizmox Enters the Business Mobile Application Market - Visual WebGui Based Solutions Deployed in Major Financial and Medical Institutions 2Gizmox Enters the Business Mobile Application Market - Visual WebGui Based Solutions Deployed in Major Financial and Medical Institutions 3AVAX Technologies, Inc. Files Form 10 With SEC 2
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
(Date:4/20/2015)... -- The announcement comes as demand for ... (GRM), Ireland,s foremost records management company, ... up an impressive track record of clients within the first ... records management sector in Dubai . As ... and employ a further eight staff members at its Irish ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... Current research suggests that a common oral bacterium may exacerbate ... "Unique Lipids from a Common Human Bacterium Represent a New ... the December 2009 issue of The American Journal of ... immune system attacks the brain and spinal cord, affects nearly ...
... 16, 2009 -- A USDOE and USDA study concluded ... and cropland pasture could be converted from current uses ... from which biomass could be harvested for use as ... grass monoculture from which substantial quantities of biomass are ...
... University of Southern California biomedical engineer and cardiologist ... tool to help clinicians distinguish cardiac emergencies requiring ... and lifestyle change. Angiograms, images made by ... offer an inside view of the interior surface ...
Cached Biology News:Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2
Recalibration of HL-2000-CAL products...
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
X-gal,1g...
Biology Products: